Sorry, you need to enable JavaScript to visit this website.

Pfizer supports the global healthcare community’s independent initiatives (e.g., research, quality improvement or education) to improve patient outcomes in areas of unmet medical need that are aligned with Pfizer’s medical and/or scientific strategies.

Pfizer’s competitive grant program involves a publicly posted Request for Proposal (RFP) that provides detail regarding a specific area of interest and sets timelines for review and approval. Organizations are invited to submit an application addressing the specific gaps in research, practice or care as outlined in the specific RFP. The grant requester (and ultimately the grantee) is responsible for the design, implementation, sponsorship, and conduct of the independent initiative supported by the grant, including compliance with any regulatory requirements.

Sign-up to receive all GMG announcements, including Request for Proposal (RFP) postings.

Sign Up for Alerts
No Records Found
Title
Grant Type Sort ascending
Focus Area
Country
Application Due Date
Transthyretin Amyloid Cardiomyopathy (ATTR-CM) Research in Canada
Release Date:
Review Process: Pfizer Internal
Translation: French (link)
Research Rare Disease Canada
Global Awards for Research in DMD-AWARD
Release Date:
Review Process: Expert Review Panel
Research Rare Disease All
Patient Preferences for Drug Delivery: Literature Review
Release Date:
Review Process: Expert Review Panel
Research Support for the Professions All
Transthyretin Amyloid Cardiomyopathy (ATTR-CM) Research in Latin America
Release Date:
Review Process: Pfizer Internal
Research Rare Disease All
Accelerating Advancements in Women’s Health
Release Date:
Partner: Myovant Sciences
Review Process: Expert Review Panel
Research Internal Medicine USA
Project to Evaluate the Effectiveness of Elranatamab in the Treatment of Multiple Myeloma
Release Date:
Partner: National Comprehensive Cancer Network
Review Process: Expert Review Panel
Research Oncology USA
Combination Therapy with Relugolix in the Treatment of Advanced Prostate Cancer
Release Date:
Partner: National Comprehensive Cancer Network; Myovant Sciences
Review Process: Expert Review Panel
Research Oncology USA
Transthyretin Amyloid Cardiomyopathy (ATTR-CM) Research
Release Date:
Review Process: Expert Review Panel
Research Rare Disease USA
Junior Investigator Global ATTR Amyloidosis Research ASPIRE (All countries except for the United States)
Release Date:
Review Process: Expert Review Panel
Research Rare Disease All
2023 Global Migraine ASPIRE
Release Date:
Review Process: Expert Review Panel
Research Internal Medicine All
2022/2023 Global COVID-19 ASPIRE
Release Date:
Review Process: Expert Review Panel
Research Hospital All
2022/2023 Global Cachexia ASPIRE
Release Date:
Review Process: Expert Review Panel
Research Internal Medicine All